BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 72 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,866,490 | +20.4% | 91,543 | +6.0% | 0.01% | +12.5% |
| Q1 2024 | $8,194,275 | +5.3% | 86,383 | +2.4% | 0.01% | 0.0% |
| Q4 2023 | $7,781,903 | +81.9% | 84,366 | -1.0% | 0.01% | +60.0% |
| Q3 2023 | $4,278,829 | -19.3% | 85,202 | +1.6% | 0.01% | -16.7% |
| Q2 2023 | $5,300,584 | +144922.8% | 83,870 | +3.2% | 0.01% | +20.0% |
| Q1 2023 | $3,655 | +3.0% | 81,233 | +0.3% | 0.01% | 0.0% |
| Q4 2022 | $3,549 | -99.9% | 81,007 | +2.1% | 0.01% | -37.5% |
| Q3 2022 | $5,229,000 | +43.6% | 79,354 | +10.0% | 0.01% | +60.0% |
| Q2 2022 | $3,642,000 | -10.1% | 72,108 | +13.7% | 0.01% | 0.0% |
| Q1 2022 | $4,052,000 | -39.5% | 63,434 | +1.5% | 0.01% | -37.5% |
| Q4 2021 | $6,695,000 | +2.0% | 62,510 | -2.1% | 0.01% | -11.1% |
| Q3 2021 | $6,565,000 | +19.1% | 63,857 | +1.9% | 0.01% | +28.6% |
| Q2 2021 | $5,513,000 | -8.9% | 62,677 | +0.7% | 0.01% | -12.5% |
| Q1 2021 | $6,049,000 | -22.8% | 62,214 | -11.0% | 0.01% | -27.3% |
| Q4 2020 | $7,837,000 | +24.4% | 69,882 | +2.8% | 0.01% | +10.0% |
| Q3 2020 | $6,302,000 | -5.0% | 67,985 | -20.0% | 0.01% | -9.1% |
| Q2 2020 | $6,631,000 | +49.2% | 85,014 | +11.8% | 0.01% | +22.2% |
| Q1 2020 | $4,445,000 | -22.0% | 76,010 | +6.9% | 0.01% | -10.0% |
| Q4 2019 | $5,696,000 | +13.9% | 71,108 | +4.5% | 0.01% | +11.1% |
| Q3 2019 | $5,000,000 | -22.4% | 68,050 | -0.3% | 0.01% | -25.0% |
| Q2 2019 | $6,440,000 | +46.8% | 68,266 | +24.6% | 0.01% | +50.0% |
| Q1 2019 | $4,387,000 | +47.0% | 54,808 | -1.0% | 0.01% | +33.3% |
| Q4 2018 | $2,984,000 | +0.9% | 55,349 | +46.1% | 0.01% | 0.0% |
| Q3 2018 | $2,956,000 | +15.1% | 37,874 | -6.4% | 0.01% | +20.0% |
| Q2 2018 | $2,568,000 | -31.6% | 40,459 | -1.1% | 0.01% | -37.5% |
| Q1 2018 | $3,752,000 | +21.6% | 40,919 | +0.0% | 0.01% | +33.3% |
| Q4 2017 | $3,085,000 | -1.7% | 40,911 | -9.2% | 0.01% | -14.3% |
| Q3 2017 | $3,137,000 | +41.7% | 45,033 | +3.0% | 0.01% | +40.0% |
| Q2 2017 | $2,214,000 | +106.0% | 43,704 | +62.6% | 0.01% | +66.7% |
| Q1 2017 | $1,075,000 | +80.1% | 26,879 | +26.3% | 0.00% | +50.0% |
| Q4 2016 | $597,000 | +1.0% | 21,274 | +6.8% | 0.00% | 0.0% |
| Q3 2016 | $591,000 | +79.6% | 19,911 | +22.6% | 0.00% | +100.0% |
| Q2 2016 | $329,000 | +37.7% | 16,241 | +79.3% | 0.00% | 0.0% |
| Q4 2015 | $239,000 | +17.2% | 9,057 | +17.5% | 0.00% | 0.0% |
| Q2 2015 | $204,000 | – | 7,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |